Immune checkpoints are important in cancer because many cancers exploit these regulatory mechanisms to evade the immune system. By upregulating certain immune checkpoint molecules, cancer cells can effectively "turn off" immune cells that would otherwise recognize and destroy them. Understanding and targeting these molecules can lead to novel therapies that enhance the body's ability to fight cancer.